Highlights of this Issue â€¢ Dans ce numÃ©ro
- Clot-busters for `brain attacks'. E.B. // Medical Update;Mar97, Vol. 20 Issue 9, p4
Examines the use of clot-dissolving drugs in treating heart attack patients. Problems faced by physicians in treating stroke; Seeming neglect of physicians on using an aggressive approach to treating stroke.
- Antithrombotic drug called useful adjunct to streptokinase. // Geriatrics;May94, Vol. 49 Issue 5, p20
Reports on a medical trial using an antithrombotic agent called Hirudin in the treatment of patients with acute myocardial infarction (MI). Usefulness as an adjunct to streptokinase; Inhibition of both free and clot-bound thrombin; Trend toward lower rates of mortality and clinical events.
- Anticoagulant Therapy in the Relatively Young Male with Myocardial Infarction. Myers Jr., John E.; Bauer, Frank L. // Annals of Internal Medicine;Nov61, Vol. 55 Issue 5, p760
Investigates anticoagulant therapy for acute myocardial infarction in young male patients. Comparison of anticoagulant and non-anticoagulant therapy; Rationale for anticoagulant therapy; Mortality rates after therapy.
- Benefits of long-term post-MI anticoagulation outweigh the costs. // Modern Medicine;Jul95, Vol. 63 Issue 7, p49
Presents an abstract of the articles `Costs and effects of long-term oral anticoagulant treatment after myocardial infarction,' by P.F.M. van Bergen, J.J.C. Jonker et al, published in the March 22-29, 1995 issue of the `Journal of the American Medical Association,' and `Economics and efficacy in...
- MI survivors: What's the optimal intensity of anticoagulation? Alexander, Sidney // Geriatrics;Aug96, Vol. 51 Issue 8, p59
Discusses the study `Optimal intensity of oral anticoagulant therapy after myocardial infarction,' by A.J. Azar, S.C. Cannegieter, J.W. Deckers, et al, published in the 1996 issue of the `Journal of American College Cardiology'.
- Oral anticoagulants--the totem and the taboo. Breckenridge, A. // British Medical Journal;2/21/1976, Vol. 1 Issue 6007, p419
Investigates the efficacy of oral anticoagulants. Controversy on the use of anticoagulants in acute myocardial infarction; Conduction of a clinical trial on the effectiveness of anticoagulants; Conclusion that anticoagulants is of no benefits as a treatment to diseases.
- What's the optimal intensify of anticoagulation in MI survivors? // Modern Medicine;Aug96, Vol. 64 Issue 8, p53
Presents an abstract of a research titled `Optimal Intensity of Oral Anticoagulant Therapy After Myocardial Infarction,' by A.J. Azar, S.C. Cannegieter, J.W. Deckers, et al, published in the May 1996 issue of `Journal of American College Cardiology.'
- SPONTANEOUS RETROPERITONEAL HEMATOMA ASSOCIATED WITH ANTITHROMBOTIC TREATMENT FOR ACUTE MYOCARDIAL INFARCTION. Popescu, Mihaela; David, Alice; Miron, A.; Giulea, C.; Popescu, Andreea; Dimulescu, Doina // Journal of Surgical Sciences;Jul-Sep2015, Vol. 2 Issue 3, p152
Retroperitoneal spontaneous hematoma is a serious condition, sometimes fatal. It occurs in association with anticoagulant therapy, unrelated to any trauma, surgery, invasive procedures or aortic aneurysm.A 68-year-old male patient is admitted for a non ST elevation myocardial infarction. He has...
- COMMENTARY: Enoxaparin was more effective than unfractionated heparin in STEMI, regardless of type of fibrinolytic agent used. Bates, Eric R. // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p63
The author reflects upon the findings of a study, that investigated the effectiveness of enoxaparin, in comparison with unfractionated heparin (UFH), for patients with ST-elevation myocardial infarction (STEMI). He states that the study suggests the use of anticoagulation for patients until...